Answers are grounded in this paper and cite their sources.
Initiation of translation for the vast majority of eukaryotic mRNAs is mediated by a 5' cap structure that binds the eukaryotic Initiation Factor 4E (eIF4E). Inhibition of eIF4E activity by 4E-BP1 does not prevent the translation of a number of capped mRNAs in the cell, indicative of the existence of previously unexplored mechanisms for the translation of these capped mRNAs without the requirement of eIF4E. Death Associated Protein 5 (DAP5), a homolog of eIFGI that lacks the eIF4E binding domain, utilizes eIF3d (a subunit of eIF3) to promote the translation of a subset of these mRNAs. Using fluorescence anisotropy-based equilibrium binding studies and luciferase reporter-based in vitro translation assays, we report the characterization of the recognition of 5' capped mRNA by eIF3d and DAP5/eIF3d complexes. eIF3d and DAP5/eIF3d complexes show differential affinity for the 5' cap of different mRNAs, with complex formation significantly enhancing cap binding. eIF3d and DAP5/eIF3d cap binding activity is inhibited by m7GDP but unaffected in the presence of GDP. We demonstrate that cap-recognition ability correlates with the efficiency of translation of these mRNAs. Surprisingly, we found that for a subset of mRNAs with highly structured 5'UTRs, DAP5 binding to the uncapped mRNA is also assisted by eIF3d. Our findings offer new insight into the use of DAP5/eIF3d for survival and growth under conditions where eIF4E is limiting in the cell (e.g. hypoxia, nutrient limitation, viral infection and proteotoxic stress). This novel mechanism of translation may offer new targets for therapeutic regulation of mRNA translation. This research is supported by the National Science Foundation Grant MCB-2317112 to D.J.G.
No takes yet. Share an insight, caveat, or question.
Quartey et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: